A Study to Evaluate the Effect of Dapagliflozin on Blood Glucose Level and Renal Safety in Patients With Type 2 Diabetes
Public ClinicalTrials.gov record NCT02413398. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Double-Blind, Placebo-Controlled, Parallel Group, Randomized, Phase III Study to Evaluate the Glycemic Efficacy and Renal Safety of Dapagliflozin in Patients With Type 2 Diabetes Mellitus and Moderate Renal Impairment (CKD 3A) Who Have Inadequate Glycemic Control.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this clinical research study is to determine whether dapagliflozin can improve (decrease) blood glucose values in patients with Type 2 diabetes and moderate renal impairment.This study will be conducted at approximately 100 centres from countries across North America and European regions. It is planned to randomize a total of 302 patients.
Study identification
- NCT ID
- NCT02413398
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 321 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 74 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 15, 2015 (Actual)
- Primary completion
- Nov 7, 2017 (Actual)
- Completion
- Nov 7, 2017 (Actual)
- Last update posted
- Oct 31, 2018
2015 – 2017
United States locations
- U.S. sites
- 27
- U.S. states
- 13
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Huntsville | Alabama | 35801 | — |
| Research Site | Burbank | California | 91505 | — |
| Research Site | Chula Vista | California | 91910 | — |
| Research Site | Concord | California | 94520 | — |
| Research Site | Fullerton | California | 92835-3404 | — |
| Research Site | Huntington Beach | California | 92648 | — |
| Research Site | Los Gatos | California | 95032 | — |
| Research Site | Newport Beach | California | 92663 | — |
| Research Site | Salinas | California | 93901-4446 | — |
| Research Site | Miami | Florida | 33015 | — |
| Research Site | Miami | Florida | 33144 | — |
| Research Site | Miami Springs | Florida | 33166 | — |
| Research Site | Pembroke Pines | Florida | 33027 | — |
| Research Site | Chicago | Illinois | 60643 | — |
| Research Site | Brownsburg | Indiana | 46112 | — |
| Research Site | Louisville | Kentucky | 40213 | — |
| Research Site | Monroe | Louisiana | 71203 | — |
| Research Site | Flint | Michigan | 48504 | — |
| Research Site | Jackson | Michigan | 39209 | — |
| Research Site | Chesterfield | Missouri | 63017 | — |
| Research Site | Kansas City | Missouri | 64111 | — |
| Research Site | Chapel Hill | North Carolina | 27517 | — |
| Research Site | Chattanooga | Tennessee | 37404 | — |
| Research Site | Houston | Texas | 77004 | — |
| Research Site | San Antonio | Texas | 78215 | — |
| Research Site | San Antonio | Texas | 78224 | — |
| Research Site | Manassas | Virginia | 20110 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 60 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02413398, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 31, 2018 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02413398 live on ClinicalTrials.gov.